Clinical identification and microbiota analysis of


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2023
Historique:
received: 02 02 2023
accepted: 29 05 2023
medline: 13 7 2023
pubmed: 12 7 2023
entrez: 12 7 2023
Statut: epublish

Résumé

Recently, the incidence of chlamydial pneumonia caused by rare pathogens such as In the present study, we investigated both the pathogenic profile characteristics and the lower respiratory tract microbiota of pneumonia patients with different chlamydial infection patterns using mNGS. More co-infecting pathogens were found to be detectable in clinical samples from patients infected with The present study provides possible evidences supporting the close correlation between chlamydial infection, altered microbial diversity in patients' lungs and clinical parameters associated with infection or inflammation in patients, which also provides a new research direction to better understand the pathogenic mechanisms of pulmonary infections caused by

Identifiants

pubmed: 37434780
doi: 10.3389/fcimb.2023.1157540
pmc: PMC10331293
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1157540

Informations de copyright

Copyright © 2023 Xie, Hu, Cao, Wu, Dai, Guo, Wang, Wei, Ren and Li.

Déclaration de conflit d'intérêts

Authors XC, WW, OW, LW and RR are employed by MatriDx Biotechnology Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.

Références

Iran J Microbiol. 2017 Oct;9(5):288-294
pubmed: 29296274
Emerg Microbes Infect. 2020 Dec;9(1):1444-1452
pubmed: 32552447
Front Genet. 2022 Mar 30;13:859727
pubmed: 35432460
Front Cell Infect Microbiol. 2022 Oct 13;12:1006117
pubmed: 36310873
Front Cell Infect Microbiol. 2022 Nov 01;12:1024867
pubmed: 36389135
Crit Care. 2022 Aug 22;26(1):252
pubmed: 35996150
Nat Rev Microbiol. 2023 Apr;21(4):222-235
pubmed: 36385637
Respir Res. 2020 May 25;21(1):129
pubmed: 32450847
Crit Rev Microbiol. 2004;30(2):75-106
pubmed: 15239381
Emerg Infect Dis. 2019 Nov;25(11):2143-2145
pubmed: 31625859
J Virol. 2020 Jun 1;94(12):
pubmed: 32269121
J Infect. 2023 Jan;86(1):24-32
pubmed: 36375640
Front Cell Infect Microbiol. 2021 Sep 13;11:708827
pubmed: 34589441
mSystems. 2021 Jun 29;6(3):e0004921
pubmed: 34100633
Microorganisms. 2019 May 24;7(5):
pubmed: 31137741
FEMS Immunol Med Microbiol. 2009 Mar;55(2):115-9
pubmed: 19281563
Ir Vet J. 2016 Jul 20;69:8
pubmed: 27446530
Front Immunol. 2022 Sep 02;13:929213
pubmed: 36119044
Tunis Med. 2022 juin;100(6):481-484
pubmed: 36206068
Front Cell Infect Microbiol. 2022 Sep 27;12:1021320
pubmed: 36237436
Genome Biol Evol. 2015 Oct 27;7(11):3070-84
pubmed: 26507799
Prog Mol Biol Transl Sci. 2022;192(1):97-124
pubmed: 36280326
Nat Med. 2021 Jan;27(1):115-124
pubmed: 33169017
Infect Dis Ther. 2022 Aug;11(4):1631-1647
pubmed: 35723864
J Med Virol. 2022 Nov;94(11):5284-5293
pubmed: 35838111
Front Cell Infect Microbiol. 2022 Dec 08;12:958722
pubmed: 36569197
Emerg Microbes Infect. 2021 Dec;10(1):1418-1428
pubmed: 34176434
Microbiol Spectr. 2022 Aug 31;10(4):e0247321
pubmed: 35943274
Int J Infect Dis. 2022 Sep;122:622-627
pubmed: 35842216
Crit Care. 2021 Jun 7;25(1):197
pubmed: 34099016
Microbiol Spectr. 2022 Feb 23;10(1):e0190121
pubmed: 35196800
Clin Chem. 2013 Apr;59(4):617-28
pubmed: 23401286
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S231-S240
pubmed: 30423048
Front Cell Infect Microbiol. 2022 Jun 06;12:872899
pubmed: 35734579
Front Microbiol. 2020 Dec 03;11:578009
pubmed: 33343522
Microbiol Spectr. 2022 Aug 31;10(4):e0238421
pubmed: 35938720
Nat Rev Microbiol. 2017 May;15(5):259-270
pubmed: 28316330
Front Immunol. 2021 Dec 08;12:797550
pubmed: 34956233
Nat Microbiol. 2020 Mar;5(3):443-454
pubmed: 31932713
Pathogens. 2022 Mar 17;11(3):
pubmed: 35335688
J Clin Diagn Res. 2016 Jun;10(6):DD01-2
pubmed: 27504286
J Infect. 2022 Nov;85(5):e127-e129
pubmed: 36031154
Thorax. 2022 Mar;77(3):283-291
pubmed: 34172558
Lancet Infect Dis. 2022 Jun;22(6):912
pubmed: 35643111
BMC Infect Dis. 2022 Feb 23;22(1):181
pubmed: 35197012
Emerg Microbes Infect. 2022 Dec;11(1):2715-2723
pubmed: 36287125
Small Methods. 2021 Jan 4;5(1):2000792
pubmed: 33614906
Lancet. 2021 Mar 27;397(10280):1213
pubmed: 33773632
Lancet Microbe. 2022 Jul;3(7):e512-e520
pubmed: 35617977
Swiss Med Wkly. 2022 Jan 11;152:w30102
pubmed: 35019255
Infection. 2020 Aug;48(4):535-542
pubmed: 32314307
Front Immunol. 2018 Nov 16;9:2640
pubmed: 30505304
Gastroenterology. 2014 May;146(6):1525-33
pubmed: 24560870
Clin Exp Allergy. 2022 Apr;52(4):518-529
pubmed: 34874580
Respirology. 2010 Jul;15(5):867-8
pubmed: 20546186
Clin Microbiol Rev. 2006 Apr;19(2):283-97
pubmed: 16614250
Syst Appl Microbiol. 2015 Mar;38(2):99-103
pubmed: 25618261
Front Cell Infect Microbiol. 2017 Dec 18;7:514
pubmed: 29326885
J Med Microbiol. 2007 Aug;56(Pt 8):1097-1100
pubmed: 17644718
Front Cell Infect Microbiol. 2022 Oct 21;12:1033427
pubmed: 36339339
BMC Pulm Med. 2021 Sep 23;21(1):300
pubmed: 34556069
J Vet Res. 2020 Dec 10;64(4):461-467
pubmed: 33367133
Medicine (Baltimore). 2022 Dec 16;101(50):e32117
pubmed: 36550834
Crit Care. 2022 Jul 6;26(1):203
pubmed: 35794610
Lancet Respir Med. 2019 May;7(5):417-426
pubmed: 30885620
Transbound Emerg Dis. 2012 Aug;59(4):283-91
pubmed: 22099945
Can J Infect Dis Med Microbiol. 2022 Jan 17;2022:7065890
pubmed: 35082959
Euro Surveill. 2014 Oct 23;19(42):
pubmed: 25358043
Schweiz Arch Tierheilkd. 2002 Sep;144(9):463-6
pubmed: 12677684

Auteurs

Gongxun Xie (G)

Department of Pathology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China.

Qing Hu (Q)

Department of Pathology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China.

Xuefang Cao (X)

Institute of Innovative Applications, MatriDx Biotechnology Co., Ltd, Hangzhou, Zhejiang, China.

Wenjie Wu (W)

Institute of Innovative Applications, MatriDx Biotechnology Co., Ltd, Hangzhou, Zhejiang, China.

Penghui Dai (P)

Department of Pathology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China.

Wei Guo (W)

Department of Pathology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China.

Ouxi Wang (O)

Institute of Innovative Applications, MatriDx Biotechnology Co., Ltd, Hangzhou, Zhejiang, China.

Liang Wei (L)

Institute of Innovative Applications, MatriDx Biotechnology Co., Ltd, Hangzhou, Zhejiang, China.

Ruotong Ren (R)

Institute of Innovative Applications, MatriDx Biotechnology Co., Ltd, Hangzhou, Zhejiang, China.
Foshan Branch, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.

Yanchun Li (Y)

Department of Pathology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan, China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH